Literature DB >> 8873676

Reduced arrhythmogenicity of biphasic versus monophasic T-wave shocks. Implications for defibrillation efficacy.

S Behrens1, C Li, P Kirchhof, F L Fabritz, M R Franz.   

Abstract

BACKGROUND: Biphasic waveforms defibrillate more effectively than monophasic waveforms; however, the mechanism remains unknown. The "upper-limit-of-vulnerability" hypothesis of defibrillation suggests that unsuccessful defibrillation is due to reinduction of ventricular fibrillation (VF). Thus, VF induction mechanisms may be important for the understanding of defibrillation mechanisms. We therefore compared myocardial VF vulnerability for monophasic versus biphasic shocks. METHODS AND
RESULTS: In 10 Langendorff-perfused rabbit hearts, monophasic and biphasic T-wave shocks were randomly administered over a wide range of shock coupling intervals and shock strengths, and the two-dimensional coordinates within which VF was induced were used to calculate the area of vulnerability (AOV) for both shock waveforms. The arrhythmic response to biphasic shocks differed from that to monophasic shocks in three distinct ways: (1) the AOV was smaller (8.9 +/- 4.2 versus 13.9 +/- 6.0 area units, P < .02), (2) the transition zone between VF-inducing and nonarrhythmogenic shocks was narrower (14.7 +/- 4.8 versus 29.9 +/- 6.4 area units, P < .001), and (3) the entire AOV shifted toward longer coupling intervals (by 11.0 +/- 8.8 ms at the left border [P < .005] and 6.0 +/- 5.2 ms at the right border [P = .005] of the AOV).
CONCLUSIONS: Biphasic shocks encounter a smaller AOV than monophasic shocks, a narrower transition zone from VF to no arrhythmia induction, and a lesser effectiveness in inducing VF at short coupling intervals. In keeping with the upper-limit-of-vulnerability hypothesis, these waveform-dependent differences in VF inducibility might help explain the lower defibrillation threshold for biphasic shocks.

Entities:  

Mesh:

Year:  1996        PMID: 8873676     DOI: 10.1161/01.cir.94.8.1974

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  8 in total

1.  Differences between left and right ventricular chamber geometry affect cardiac vulnerability to electric shocks.

Authors:  Blanca Rodríguez; Li Li; James C Eason; Igor R Efimov; Natalia A Trayanova
Journal:  Circ Res       Date:  2005-06-23       Impact factor: 17.367

2.  [Pathophysiologic relevance and prognostic value of QT dispersion].

Authors:  M Zabel; S H Hohnloser
Journal:  Herzschrittmacherther Elektrophysiol       Date:  1997-12

Review 3.  Using Nanosecond Shocks for Cardiac Defibrillation.

Authors:  Johanna U Neuber; Frency Varghese; Andrei G Pakhomov; Christian W Zemlin
Journal:  Bioelectricity       Date:  2019-12-12

Review 4.  [Transthoracic defibrillation. Physiologic and pathophysiologic principles and their role in the outcome of resuscitation].

Authors:  V Lischke; P Kessler; C Byhahn; K Westphal; A Amann
Journal:  Anaesthesist       Date:  2004-02       Impact factor: 1.041

Review 5.  Electrical Stimulation for Low-Energy Termination of Cardiac Arrhythmias: a Review.

Authors:  Skylar Buchan; Ronit Kar; Mathews John; Allison Post; Mehdi Razavi
Journal:  Cardiovasc Drugs Ther       Date:  2021-08-07       Impact factor: 3.727

Review 6.  Optimizing defibrillation waveforms for ICDs.

Authors:  Mark W Kroll; Charles D Swerdlow
Journal:  J Interv Card Electrophysiol       Date:  2007-06-01       Impact factor: 1.900

7.  Mechanically Induced Ectopy via Stretch-Activated Cation-Nonselective Channels Is Caused by Local Tissue Deformation and Results in Ventricular Fibrillation if Triggered on the Repolarization Wave Edge (Commotio Cordis).

Authors:  T Alexander Quinn; Honghua Jin; Peter Lee; Peter Kohl
Journal:  Circ Arrhythm Electrophysiol       Date:  2017-08

8.  Excitation and injury of adult ventricular cardiomyocytes by nano- to millisecond electric shocks.

Authors:  Iurii Semenov; Sergey Grigoryev; Johanna U Neuber; Christian W Zemlin; Olga N Pakhomova; Maura Casciola; Andrei G Pakhomov
Journal:  Sci Rep       Date:  2018-05-29       Impact factor: 4.379

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.